GEN

EU Approves Biogen Idec’s Avonex Intramuscular Autoinjector Product for MS

Study showed 94% of patients preferred new device over existing Avonex prefilled syringe. The European regulatory authorities approved Biogen Idec’s single-use intramuscular autoinjector, Avonex PEN, ...
BioWorld

Avonex(t): FDA gives nod to Plegridy for MS, oral Tecfidera still Biogen mouth that roared

Biogen Idec Inc. is keeping its injectable bases covered in relapsing multiple sclerosis (RMS) with the approval Friday of Plegridy (peginterferon beta-1a), given by an auto-injector pen or prefilled ...
FierceBiotech

Biogen Idec Receives Approval in the European Union for AVONEX® PEN™

European Commission approves the first single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX (interferon beta-1a) administration “At Biogen Idec, our commitment ...
FierceBiotech

FDA Approves AVONEX® PEN™ and Dose Titration Regimen

Dosing Enhancements May Improve Treatment Experience for Patients Receiving AVONEX® (interferon beta-1a) for Multiple Sclerosis WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) ...
FiercePharma

Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN

-- First single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX recommended for approval in the European Union and authorised in Canada -- AVONEX PEN is designed ...
Monthly Prescribing Reference

Avonex Pen and New Dose Titration Regimen Available

AVONEX PEN (interferon beta-1a) 30mcg/0.5mL solution for injection by Biogen Idec The Avonex Pen (interferon beta-1a 30mcg/0.5mL solution for injection), the first IM autoinjector for chronic use in ...
Boston.com

Biogen Idec submits FDA application for promising MS drug

Biogen Idec Inc., a Weston-based biotechnology company known for its multiple sclerosis drugs, said it has submitted a New Drug Application to federal regulators to get approval to market a potential ...
Monthly Prescribing Reference

FDA Approves Avonex Pen and Dose Titration Regimen

AVONEX PEN (interferon beta-1a) 30mcg/0.5mL solution for injection by Biogen Idec Biogen Idec has received approval from the FDA for Avonex Pen (30mcg/0.5mL solution for injection) for patients ...
The Boston Globe

Biogen Idec submits FDA application for MS drug

Biogen Idec Inc., a Weston-based biotechnology company known for its multiple sclerosis drugs, said it has submitted a New Drug Application to federal regulators to get approval to market a potential ...